Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 775.30M | 739.44M | 607.39M | 648.55M | 655.59M |
Gross Profit | 473.57M | 430.12M | 316.46M | 331.99M | 354.41M |
EBITDA | -45.50M | 14.18M | -135.08M | -97.26M | -147.73M |
Net Income | -683.70M | -146.42M | -316.52M | 48.66M | -200.55M |
Balance Sheet | |||||
Total Assets | 3.50B | 3.98B | 4.39B | 5.00B | 5.25B |
Cash, Cash Equivalents and Short-Term Investments | 385.11M | 605.57M | 961.61M | 1.33B | 1.69B |
Total Debt | 1.13B | 817.65M | 1.03B | 1.15B | 1.31B |
Total Liabilities | 1.43B | 1.15B | 1.37B | 1.54B | 1.77B |
Stockholders Equity | 1.78B | 2.50B | 2.67B | 3.08B | 3.12B |
Cash Flow | |||||
Free Cash Flow | 165.88M | -85.08M | -30.86M | 55.40M | -55.65M |
Operating Cash Flow | 196.61M | -38.46M | 6.57M | 95.11M | -5.64M |
Investing Cash Flow | -406.44M | -11.16M | 148.78M | -79.67M | -138.40M |
Financing Cash Flow | 196.79M | -302.39M | -279.04M | -228.87M | 185.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | 674.18M | 7.03 | 34.76% | 7.82% | 19.11% | 5.40% | |
64 Neutral | 1.11B | 12.17 | 0.00% | 5.50% | 4.16% | 59.08% | |
57 Neutral | 1.11B | 93.58 | -0.69% | 6.34% | 0.26% | -73.09% | |
51 Neutral | HK$771.70M | ― | -30.50% | ― | 6.56% | -179.13% | |
51 Neutral | 1.01B | -4.76 | -51.76% | 6.52% | -21.42% | 55.86% | |
50 Neutral | 252.28M | 19.89 | 2.66% | 19.55% | -5.04% | -67.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
Lippo China Resources Limited announced that the Proposed Capital Reduction has become effective as of July 29, 2025, following the fulfillment of all necessary conditions and registration with the Registrar. This move is likely to impact the company’s financial structure and may influence its market positioning and stakeholder interests.
Lippo China Resources Limited announced a conditional special distribution of its shares by its parent company, Lippo Limited. This distribution will change the shareholding structure, allowing Lippo shareholders to receive shares in Lippo China Resources or cash. The board does not anticipate any negative impact on the group’s operations from this distribution.
Lippo China Resources Limited announced that all resolutions proposed at its Annual General Meeting on June 23, 2025, were approved by shareholders. The resolutions included the adoption of financial statements, re-election of directors, and granting mandates for share issuance and buy-back. The approval of these resolutions indicates strong shareholder support and may positively impact the company’s strategic flexibility and governance.
Lippo China Resources Limited, a company listed on the Hong Kong Stock Exchange, has announced a potential distribution in specie of its shares by its parent company, Lippo Limited. This distribution, which involves up to 303,289,730 ordinary shares, is conditional upon the satisfaction of certain conditions and is part of a broader proposal that includes the privatization of Lippo. Trading of Lippo China Resources Limited’s shares, which was previously halted, is set to resume on May 29, 2025.
Lippo China Resources Limited has announced its upcoming Annual General Meeting, scheduled for June 23, 2025, at the Renaissance Harbour View Hotel in Hong Kong. The meeting will address several key issues, including the adoption of the company’s audited financial statements for the year ending December 31, 2024, the re-election of directors, and the re-appointment of Ernst & Young as auditors. Additionally, the company seeks approval for the directors to have the authority to allot and issue additional shares, subject to certain conditions. This announcement highlights the company’s ongoing governance practices and strategic planning efforts, which may impact its operational and financial strategies moving forward.
Lippo China Resources Limited has announced a trading halt on the Hong Kong Stock Exchange as of May 19, 2025, pending the release of inside information. This halt could indicate significant developments within the company that may impact its operations and market position, affecting stakeholders and investors.
Lippo China Resources Limited has announced a proposed capital reduction, aiming to decrease its share capital account by HK$1,554,031,044.03 to HK$150,000,000.00. This move is intended to address the company’s accumulated losses of HK$636,154,722.71, enabling it to have greater flexibility in undertaking corporate exercises and potentially declaring distributions or dividends in the future. The proposal is subject to several conditions, including shareholder approval and regulatory consents, and is considered by the Board to be in the best interests of the company and its shareholders.